S-SELeCT: a human-evolved serine integrase system for efficient large-cargo genome integration
Nucleic Acids Research · 2026
DOI: 10.1093/nar/gkag286 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nucleic Acids Research, 2026. Verfasst von Alfonso P Farruggio und 5 weiteren Autor:innen. Beteiligte Einrichtung: Research and Development, Applied StemCell Inc., Milpitas, CA 95035, United States. Hauptthemen laut MEDLINE: Integrases, Gene Knock-In Techniques. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIH HHS, Applied StemCell's Research and Development funds, National Institutes of Health.
Abstract (Originalsprache)
As a consequence of their sizes, many loss-of-function genetic mutations fall within large genes. A major gene-therapy tool that could be used to solve large swaths of the genetic diseases that result from these inherited mutations is large-fragment knock-in. I.e. instead of attempting to create separate treatments for each and every location that these mutations occur in, large groups of patients could be aided via a single safe-harbor integration of the full-length coding sequence. Toward this goal, we have created a set of early stage gene-editing enzymes that can help mediate large cargo integration at a safe harbor locus in human cells. When expressed in stable lines, our S-SELeCT (Site-Specific Large Cargo Targeting) integrase fusions can facilitate integration of a 10 kb plasmid at frequencies up to 32%, and when delivered transiently via plasmid transfection, we were able to achieve up to 13% knock-in. These are the first serine integrase enzymes that have been evolved fully in human cells and the first to recognize an endogenous symmetric non-pseudosite—the first true human serine integrase attachment site.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Research and Development, Applied StemCell Inc., Milpitas, CA 95035, United States.
ORCID-Profile: Alfonso P Farruggio
Förderung
- NIH HHS
- Applied StemCell's Research and Development funds
- National Institutes of Health
Zitieren
APA
Farruggio, A. P., Jiang, L., Duong, K., Nguyen, C., Kaddoura, R., & Tsai, R. (2026). S-SELeCT: a human-evolved serine integrase system for efficient large-cargo genome integration. Nucleic Acids Research. https://doi.org/10.1093/nar/gkag286
Vancouver
Farruggio AP, Jiang L, Duong K, Nguyen C, Kaddoura R, Tsai R. S-SELeCT: a human-evolved serine integrase system for efficient large-cargo genome integration. Nucleic Acids Research. 2026. doi:10.1093/nar/gkag286
BibTeX
@article{Farruggio2026,
author = {Farruggio, Alfonso P and Jiang, Lin and Duong, Karen and Nguyen, Cynthia and Kaddoura, Razan and Tsai, Ruby},
title = {S-SELeCT: a human-evolved serine integrase system for efficient large-cargo genome integration},
journal = {Nucleic Acids Research},
year = {2026},
doi = {10.1093/nar/gkag286}
}
EUVIMED